Castle Biosciences, Inc.CSTLNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
3.30%
↑ 117% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-18.98%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.30% | -71.3% |
| 2024 | 11.48% | +156.1% |
| 2023 | -20.49% | +51.9% |
| 2022 | -42.57% | -9.4% |
| 2021 | -38.91% | -243.6% |
| 2020 | -11.32% | -157.1% |
| 2019 | 19.82% | +220.0% |
| 2018 | -16.51% | +78.2% |
| 2017 | -75.61% | - |